Categories
- PROTAC Linker
- Protein Control Ligand
- Pathway Inhibitors
- Function Modulators
- Activators
- G Protein-Coupled Receptor Ligands
- Nuclear Receptor Ligands
- GDNF Receptors
- TNF Receptors
- Transcription Factors
- Chemokines
- Cytokine Receptors
- Biomarkers and Buffer Solutions
- Molecular Probes
- Stem Cell Research
- Alzheimer's Disease
- Apoptosis
- Cancer Research
- Epigenetics
- Metabolites
- PET/SPECT Imaging Precursors
- Customized Screening Library
- Ultra Pure Pharmacological Standard
- Tissue Microarray (TMA)
- Proteins and Antibodies
- Primary Cells
- ELISA KIT
- Natural Products
- Lab Equipments
- Humanized Mice for PDX Platform
- Rare Chemicals
- Custom Synthesis
- Antibacterial
- Antifungal
- Antioxidant
- Antiviral
- Molecular Glues
- SARS-CoV
Quantity Discount Table - Order More To Get More Price Discount
| Quantity | mg | Unit Price ($/mg or $/Unit) | Final Price |
|---|---|---|---|
| 1 | 5 | $79.05 | Total: $395.25 |
| 1 | 10 | $66.96 | Total: $669.60 |
| 1 | 25 | $56.73 | Total: $1,418.25 |
| 1 | 50 | $48.36 | Total: $2,418.00 |
| 1 | 100 | $41.85 | Total: $4,185.00 |
Overview
AMPK-IN-3 is a novel, selective and potent AMPK inhibitor with inhibitory effects on AMPK (?2), AMPK (?1) and KDR, with IC50 values of 60.7, 107 and 3820 nM, respectively.AMPK-IN-3 showed anticancer activity in K562 cells.
Chemical Properties
| Molecular Formula | C25H33N5O3 |
| Molecular Weight | 451.56 |
| CAS Numbers | 2417674-27-0 |
| Solubility | DMSO |
| Purity | 98% by HPLC |
| SMILES Code | CCN(CC)CCNC(=O)c1c(C)[nH]c(C=C2C(=O)Nc3ccc(CCC(N)=O)cc23)c1C |
Storage and Handling
0C Short Term, -20C Long Term
References
Matheson CJ, et al. Substituted oxindol-3-ylidenes as AMP-activated protein kinase [AMPK] inhibitors. Eur J Med Chem. 2020 Jul 1;197 112316.